Can Mean Platelet Volume be a New Risk Factor in Portal Venous Thrombosis?
dc.contributor.author | Aliosmanoglu, Ibrahim | |
dc.contributor.author | Gul, Mesut | |
dc.contributor.author | Oguz, Abdullah | |
dc.contributor.author | Basol, Omer | |
dc.contributor.author | Uslukaya, Omer | |
dc.contributor.author | Keles, Celalettin | |
dc.date.accessioned | 2024-04-24T17:14:38Z | |
dc.date.available | 2024-04-24T17:14:38Z | |
dc.date.issued | 2013 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Background: The aim of this study was to discuss the possibility of mean platelet volume (MPV) being a new risk factor in the etiology of portal venous thrombosis (PVT). Methods: Study participants were categorized into 2 different groups: group I, control group (n = 35) and group II, PVT group (n = 34). Demographic data and MPV values were recorded retrospectively. Results: No differences were determined between the 2 groups regarding hypertension, diabetes mellitus, and smoking (P > .05). The average hemoglobin levels were 10.8 +/- 2.1 in group II and 14.0 +/- 1.7 in group I (P < .001). Although the MPV levels of group II patients were 8.2 +/- 0.52, the average level in group I was determined as 7.8 +/- 0.62 (P = .012). In the performed receiver-operating characteristic (ROC) analysis, the cutoff value for patients with PVT for MPV was determined as 7.9 (area under curve: 0.674), sensitivity as 70.6%, and specificity as 65.7% (P = .013). Conclusion: The current study shows that MPV is significantly higher in patients with PVT than in the control group. | en_US |
dc.identifier.doi | 10.1177/1076029612464903 | |
dc.identifier.endpage | 436 | en_US |
dc.identifier.issn | 1076-0296 | |
dc.identifier.issn | 1938-2723 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 23162018 | |
dc.identifier.scopus | 2-s2.0-84879955766 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 433 | en_US |
dc.identifier.uri | https://doi.org/10.1177/1076029612464903 | |
dc.identifier.uri | https://hdl.handle.net/11468/18114 | |
dc.identifier.volume | 19 | en_US |
dc.identifier.wos | WOS:000321308000012 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications Inc | en_US |
dc.relation.ispartof | Clinical and Applied Thrombosis-Hemostasis | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Portal Venous Thrombosis | en_US |
dc.subject | Mean Platelet Volume | en_US |
dc.subject | Etiology | en_US |
dc.title | Can Mean Platelet Volume be a New Risk Factor in Portal Venous Thrombosis? | en_US |
dc.title | Can Mean Platelet Volume be a New Risk Factor in Portal Venous Thrombosis? | |
dc.type | Article | en_US |